doi: 10.1210/clinem/dgaa863 Summary Keywords obesity, insulin-resistance, Tirzepatide, pathophysiology, GIP, GLP - 1, clinical trials, arterial hypertension Citation Corrao S, Pollicino C, Maggio D, Torres A and Argano C (2024) Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence
The now-elevated calcium levels promote exocytosis of GLP-1containing vesicles, releasing GLP-1 into the circulation
Instead, licensed professionals evaluate metabolic health, medical history, and long-term goals before recommending a therapy plan
Cell Metabolism, 3(3), 153-165